Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro

B Mao, VTK Le-Trilling, K Wang… - Emerging Microbes & …, 2022 - Taylor & Francis
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is …

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro

B Mao, VTK Le-Trilling, K Wang, D Mennerich, J Hu… - 2022 - agris.fao.org
Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is an urgent …

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro

B Mao, VTK Le-Trilling, K Wang… - Emerging Microbes …, 2022 - search.proquest.com
Abstract Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is …

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.

B Mao, VTK Le-Trilling, K Wang, D Mennerich, J Hu… - 2022 - cabidigitallibrary.org
Abstract Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is …

[HTML][HTML] Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro

B Mao, VTK Le-Trilling, K Wang… - Emerging Microbes & …, 2022 - ncbi.nlm.nih.gov
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is …

[PDF][PDF] Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro

B Mao, VTK Le-Trilling, K Wang… - Emerging Microbes …, 2022 - scienceopen.com
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is …

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro

B Mao, VTK Le-Trilling, K Wang… - Emerging …, 2022 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is an urgent …

[PDF][PDF] Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro

B Mao, VTK Le-Trilling, K Wang… - Emerging Microbes & …, 2022 - researchgate.net
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is …

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.

B Mao, VTK Le-Trilling, K Wang… - Emerging Microbes & …, 2022 - europepmc.org
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is …

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.

B Mao, VTK Le-Trilling, K Wang… - Emerging Microbes & …, 2022 - europepmc.org
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by the emerging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has set off a global pandemic. There is …